Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Dba Centerspace | CSR | Jan 30, 2025 | 60.99 | +0.48 |
DBA Sempra | SRE | Jan 30, 2025 | 83.29 | +1.60 |
DBV Technologies ADR | DBVT | Jan 30, 2025 | 4.26 | +0.95 |
DDC Enterprise | DDC | Jan 30, 2025 | 0.15 | -8.04 |
Decent Holding | DXST | Jan 30, 2025 | 1.70 | 0.00 |
Deckers Outdoor | DECK | Jan 30, 2025 | 223.11 | +1.92 |
Deere & Co. | DE | Jan 30, 2025 | 479.99 | +0.38 |
DEFA Equity Income Wisdomtree | DTH | Jan 30, 2025 | 39.35 | +1.02 |
DEFA Wisdomtree | DWM | Jan 30, 2025 | 55.54 | +1.11 |
Definitive Healthcare | DH | Jan 30, 2025 | 4.92 | -0.20 |
Delcath Systems | DCTH | Jan 30, 2025 | 15.97 | +2.04 |
Delek Logistics Partners LP Unit | DKL | Jan 30, 2025 | 44.33 | +1.86 |
Delek US | DK | Jan 30, 2025 | 18.34 | -1.45 |
Dell Technologies C | DELL | Jan 30, 2025 | 105.35 | +2.18 |
Delta Air Lines | DAL | Jan 30, 2025 | 68.57 | +0.20 |
Deluxe | DLX | Jan 30, 2025 | 23.42 | +2.36 |
Denali Capital Acquisition A | DECA | Jan 30, 2025 | 12.00 | 0.00 |
Denali Therapeutics | DNLI | Jan 30, 2025 | 23.58 | +0.73 |
Denison Mines | DNN | Jan 30, 2025 | 1.92 | +3.78 |
Dennys | DENN | Jan 30, 2025 | 6.42 | +0.63 |
DENTSPLY SIRONA | XRAY | Jan 30, 2025 | 20.31 | +3.46 |
Dermata Therapeutics | DRMA | Jan 30, 2025 | 1.20 | -0.83 |
Descartes Systems Group | DSGX | Jan 30, 2025 | 117.46 | +1.31 |
Design Therapeutics | DSGN | Jan 30, 2025 | 4.97 | +0.61 |
Designer Brands A | DBI | Jan 30, 2025 | 5.13 | +1.38 |
Desktop Metal A | DM | Jan 30, 2025 | 2.50 | +15.21 |
Despegar.com | DESP | Jan 30, 2025 | 19.18 | -0.21 |
Destiny Tech100 | DXYZ | Jan 30, 2025 | 56.86 | +1.23 |
Destra Multialternative Fund | DMA | Jan 30, 2025 | 8.73 | 0.00 |
Deswell Industries | DSWL | Jan 30, 2025 | 2.38 | -0.42 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.